Danimer Scientific Statistics
Share Statistics
Danimer Scientific has 3.02M shares outstanding. The number of shares has increased by -97.36% in one year.
| Shares Outstanding | 3.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -97.5% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.46M |
| Failed to Deliver (FTD) Shares | 1.04K |
| FTD / Avg. Volume | 1.14% |
Short Selling Information
The latest short interest is 494.21K, so 16.37% of the outstanding shares have been sold short.
| Short Interest | 494.21K |
| Short % of Shares Out | 16.37% |
| Short % of Float | 18.15% |
| Short Ratio (days to cover) | 4.96 |
Valuation Ratios
The PE ratio is -26.77 and the forward PE ratio is -0.53.
| PE Ratio | -26.77 |
| Forward PE | -0.53 |
| PS Ratio | 89.15 |
| Forward PS | 0.1 |
| PB Ratio | 14.97 |
| P/FCF Ratio | -55.53 |
| PEG Ratio | n/a |
Enterprise Valuation
Danimer Scientific Inc. has an Enterprise Value (EV) of 512.11M.
| EV / Earnings | -3.29 |
| EV / Sales | 10.97 |
| EV / EBITDA | -5.33 |
| EV / EBIT | -4.08 |
| EV / FCF | -6.83 |
Financial Position
The company has a current ratio of 6.87, with a Debt / Equity ratio of 1.38.
| Current Ratio | 6.87 |
| Quick Ratio | 5.26 |
| Debt / Equity | 1.38 |
| Total Debt / Capitalization | 57.93 |
| Cash Flow / Debt | -0.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.56% and return on capital (ROIC) is -18.35%.
| Return on Equity (ROE) | -0.56% |
| Return on Assets (ROA) | -0.22% |
| Return on Capital (ROIC) | -18.35% |
| Revenue Per Employee | 181.65K |
| Profits Per Employee | -604.95K |
| Employee Count | 257 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | 319.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -89.05% in the last 52 weeks. The beta is 1.63, so Danimer Scientific 's price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -89.05% |
| 50-Day Moving Average | 7.44 |
| 200-Day Moving Average | 20.2 |
| Relative Strength Index (RSI) | 31.8 |
| Average Volume (20 Days) | 91.60K |
Income Statement
In the last 12 months, Danimer Scientific had revenue of 46.68M and earned -155.47M in profits. Earnings per share was -1.52.
| Revenue | 46.68M |
| Gross Profit | -26.96M |
| Operating Income | -125.62M |
| Net Income | -155.47M |
| EBITDA | -96.13M |
| EBIT | -125.62M |
| Earnings Per Share (EPS) | -1.52 |
Balance Sheet
The company has 59.17M in cash and 408.07M in debt, giving a net cash position of -348.90M.
| Cash & Cash Equivalents | 59.17M |
| Total Debt | 408.07M |
| Net Cash | -348.90M |
| Retained Earnings | -454.12M |
| Total Assets | 643.77M |
| Working Capital | 48.54M |
Cash Flow
In the last 12 months, operating cash flow was -47.26M and capital expenditures -27.68M, giving a free cash flow of -74.95M.
| Operating Cash Flow | -47.26M |
| Capital Expenditures | -27.68M |
| Free Cash Flow | -74.95M |
| FCF Per Share | -0.73 |
Margins
Gross margin is -5.78K%, with operating and profit margins of -26.91K% and -33.30K%.
| Gross Margin | -5.78K% |
| Operating Margin | -26.91K% |
| Pretax Margin | -33.23K% |
| Profit Margin | -33.30K% |
| EBITDA Margin | -205.91% |
| EBIT Margin | -269.08% |
| FCF Margin | -160.55% |
Dividends & Yields
DNMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -36.8% |
| FCF Yield | -600.93% |
Analyst Forecast
The average price target for DNMR is $40, which is 868.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $40 |
| Price Target Difference | 868.5% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Nov 13, 2024. It was a backward split with a ratio of 1:40.
| Last Split Date | Nov 13, 2024 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -1.4 |
| Piotroski F-Score | 1 |